Trendy Mod­er­na's sin­gle-as­set CF pact with Ver­tex marks a new phase of deal­mak­ing

Just a few days af­ter Mod­er­na wrapped up a $200 mil­lion-up­front re­search deal with Mer­ck, the Boston biotech is back with an­oth­er pact – this …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA